Evidence map›Paper›PMID 40198526›Full record

ArticleAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2025

Detection of a large antigen through the masking and exposure of a fragment of split luciferase.

Cheng Qian, Ayumu Ninomiya, Natsuki Shibukawa, Hiroshi Ueda, Takanobu Yasuda, Bo Zhu, Tetsuya Kitaguchi

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cheng QianGraduate School of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan.
Ayumu NinomiyaGraduate School of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan.
Natsuki ShibukawaGraduate School of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan.
Hiroshi UedaLaboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-Ku, Yokohama, 226-8501, Japan.
Takanobu YasudaLaboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-Ku, Yokohama, 226-8501, Japan.
Bo ZhuLaboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-Ku, Yokohama, 226-8501, Japan.
Tetsuya KitaguchiLaboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-Ku, Yokohama, 226-8501, Japan. kitaguc.t.aa@m.titech.ac.jp.ORCID http://orcid.org/0000-0001-6701-1933

Funding

Institute of Innovative Research, Tokyo Institute of Technology Pioneering Research from Organization for Fundamental ResearchJapan Science and Technology Agency JPMJSP2106Japan Society for the Promotion of Science JP22H05176Japan Society for the Promotion of Science JP24H01123Japan Society for the Promotion of Science JP24K01264
6 · The paper itself

Abstract

We developed PMBiT, an antibody-binding Protein M (PM)-based bioluminescent probe that detects large antigens via luciferase reconstitution by exposing a luciferase fragment. Detection is achieved by exploiting the principle that the antibody, large antigen, and PM cannot form a complex simultaneously. PMBiT was prepared by conjugating PM with a HiBiT-based peptide from split NanoLuc luciferase through an Azide-DBCO click reaction. It retained its binding activity to the antibody and showed bioluminescence upon reconstitution of the luciferase with LgBiT, the other fragment of the split NanoLuc. Mixing PMBiT with various IgG antibodies resulted in decreased bioluminescence. In contrast, when PMBiT was mixed with IgG bound to its large antigen, such as human C-reactive protein, a dose-dependent increase in bioluminescence was obtained. Molecular dynamics simulations of PM showed that two regions in the C-terminus contribute to steric clashes with antigens owing to their relatively rigid structures. Furthermore, in silico analysis of the structure suggested that the antigen size was the primary factor blocking the binding of PMBiT to IgG for antigen detection. An immunoassay utilizing PMBiT does not require genetic manipulation of antibodies, allowing for seamless and scalable antibody replacement, and will advance the future of on-site detection and rapid diagnostics.

Indexed as

AntigensLuciferasesHumansImmunoassayImmunoglobulin GLuminescent MeasurementsMolecular Dynamics SimulationAntigensImmunoglobulin GLuciferasesHomogeneous immunoassayNanoLucProtein MSplit luciferase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.